Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61

United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$8.91M

$1.46M on a plan · $1.66M straight out of an exercise

Sold at will

$5.79M

3 of 20 sales

Net

−$8.91M

−$5.79M against sales at will